HI
ONCY

Harbour Investments’s Oncolytics Biotech ONCY Stock Holding History

Harbour Investments’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,330
Closed -$5K – 3367
2021
Q3 		$5K Hold
2,330
– – ﹤0.01% 3003
2021
Q2 		$6K Hold
2,330
– – ﹤0.01% 2983
2021
Q1 		$9K Buy
+2,330
New +$6.95K ﹤0.01% 2669

Other funds holding ONCY

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
ARC
Advisor Resource Council Dallas, Texas $355M AUM 30.05% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Harbour Investments's ONCY Position: Q4 2021 in Review

Harbour Investments sold out of Oncolytics Biotech (ONCY) in Q4 2021, closing a stake of 2,330 shares — an estimated $5K sold.

Harbour Investments first reported a position in ONCY in Q1 2021 and held it in 3 quarters. The position peaked at $9K in Q1 2021. 45 funds tracked by Wall St. Rank hold ONCY as of Q4 2021.

  • Harbour Investments reported no remaining Oncolytics Biotech position as of Q4 2021 after selling out during the quarter.
  • Harbour Investments sold 2,330 Oncolytics Biotech shares in Q4 2021, an estimated $5K.
  • Harbour Investments first reported a position in Oncolytics Biotech in Q1 2021 and held it in 3 quarters.
  • Harbour Investments's Oncolytics Biotech position peaked at $9K in Q1 2021.
  • 45 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q4 2021.

Based on Harbour Investments's 13F filing for Q4 2021, filed 16 Feb 2022.